AI Navigate

Towards Fair and Robust Volumetric CT Classification via KL-Regularised Group Distributionally Robust Optimisation

arXiv cs.CV / 3/18/2026

📰 NewsSignals & Early TrendsIdeas & Deep AnalysisModels & Research

Key Points

  • The paper addresses distribution shift across acquisition sites and demographic disparities in chest CT diagnosis by proposing a KL-regularised Group DRO framework for two tasks.
  • It combines a lightweight MobileViT-XXS slice encoder with a two-layer SliceTransformer and uses a KL-regularised Group DRO objective to upweight underperforming groups without collapsing group weights.
  • In Task 1 (COVID-19 binary classification across multi-site CT volumes) it achieves a challenge F1 of 0.835, surpassing the best published entry by 5.9 points.
  • In Task 2 (four-class lung pathology with gender-based fairness constraints) it reaches a mean per-gender macro F1 of 0.815, outperforming the best entry by 11.1 percentage points and boosting Female Squamous F1 by 17.4 over the focal loss baseline.

Abstract

Automated diagnosis from chest computed tomography (CT) scans faces two persistent challenges in clinical deployment: distribution shift across acquisition sites and performance disparity across demographic subgroups. We address both simultaneously across two complementary tasks: binary COVID-19 classification from multi-site CT volumes (Task 1) and four-class lung pathology recognition with gender-based fairness constraints (Task 2). Our framework combines a lightweight MobileViT-XXS slice encoder with a two-layer SliceTransformer aggregator for volumetric reasoning, and trains with a KL-regularised Group Distributionally Robust Optimisation (Group DRO) objective that adaptively upweights underperforming acquisition centres and demographic subgroups. Unlike standard Group DRO, the KL penalty prevents group weight collapse, providing a stable balance between worst-case protection and average performance. For Task 2, we define groups at the granularity of gender class, directly targeting severely underrepresented combinations such as female Squamous cell carcinoma. On Task 1, our best configuration achieves a challenge F1 of 0.835, surpassing the best published challenge entry by +5.9. On Task 2, Group DRO with {\alpha} = 0.5 achieves a mean per-gender macro F1 of 0.815, outperforming the best challenge entry by +11.1 pp and improving Female Squamous F1 by +17.4 over the Fo- cal Loss baseline.